NCT06741982
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, HNSCC, +10 more
- Locations
-
- West China Hospital, Sichuan University Chengdu, Sichuan, China
Clinical trial condition
HNSCC
Explore clinical trials studying HNSCC. Study availability and eligibility vary by location and protocol.
72 public trials
36 recruiting studies
HNSCC trial results
Recruiting
Safety and Efficacy of VB10.16 and Pembrolizumab in Patients with Head-Neck Squamous Cell Carcinoma
NCT06016920
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Disease Attributes, +13 more
- Locations
-
- Fakultni nemocnice Olomouc, Olomuoc Olomouc, Czechia
- Hôpital de la Pitié - Salpétrière in Paris Paris, France
- Hospices Civils De Lyon Lyon, France
- CRLC Val d'Aurelle - Institut de Recherche en Cancerologie de Montpellier (IRCM) Montpellier, France
Recruiting
A Study of SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid Tumors
NCT06259552
- Conditions
- CRC, Carcinoma, Carcinoma, Squamous Cell, +9 more
- Locations
-
- Mayo Clinic Arizona Phoenix, Arizona, United States
- HonorHealth Research and Innovation Institute Scottsdale, Arizona, United States
- Mayo Clinic Florida Jacksonville, Florida, United States
- Mayo Clinic Rochester Rochester, Minnesota, United States
NCT05192655
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, HNSCC, +6 more
- Locations
-
- Department of Radiooncology and Radiotherapy, Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum Berlin, Germany
NCT05980702
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, HNSCC, +11 more
- Locations
-
- Sun yat-sen memorial hospital Guangzhou, Guangdong, China
NCT05980715
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, HNSCC, +8 more
- Locations
-
- Sun yat-sen memorial hospital Guangzhou, Guangdong, China
Not Yet Recruiting
A Phase II Study to Evaluate the Efficacy and Safety of SKB571 in Recurrent or Metastatic HNSCC Participants
NCT07668154
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, HNSCC, +6 more
- Locations
-
- West China Hospital, Sichuan University Chengdu, China
- Shanghai Oriental Hospital Shanghai, China
Not Yet Recruiting
Nano-Carbon Iron Suspension Injection Combined With Radiotherapy for Solid Tumors Phase II Clinical Trial
NCT07491783
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, HNSCC, +9 more
- Locations
-
- West China Hospital, Sichuan University Chengdu, Sichuan, China
Not Yet Recruiting
Neutrophil Biomarker Test for Predicting Clinical Benefit From Immunotherapy Based on Flow Cytometry Analysis
NCT07246759
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +41 more
- Locations
-
- Heidelberg University Hospital Heidelberg, Germany
- Intituto Europeo di Oncologia SRL Milan, Italy
- Virgen Macarena University Hospital - Servicio Andaluz de Salud Seville, Spain
Not Yet Recruiting
PD-1 Inhibitor Therapy Versus Radiotherapy in MPR Patients With Locally Advanced HNSCC After Neoadjuvant Immunochemotherapy (HNC-SYSU-006)
NCT07090707
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, HNSCC, +8 more
- Locations
-
- Sun yat-sen memorial hospital Guangzhou, Guangdong, China